Probing the Myeloma Immune MicroEnvironment One Cell at A Time (Single-Cell Sequencing)
Join us to discuss how experts are using the latest single-cell sequencing technologies to improve immunotherapies for myeloma. This is for all curious myeloma patients and their loved ones.
Audrey introduces the agenda of the event and featured speaker Dr. David Coffey
Dr. David Coffey discusses how experts are using the latest single-cell sequencing technologies to improve immunotherapies for myeloma.
Type your questions in the chat and we will answer them!
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
David Coffey, M.D.
David Coffey, MD, is an Assistant Professor of Medicine in the Division of Myeloma at the University of Miami’s Sylvester Comprehensive Cancer Center. He is a computational oncologist focused on precision medicine approaches for multiple myeloma. His research examines how myeloma cells interact with the immune system using advanced single-cell and genomic analyses to understand treatment resistance and identify strategies to strengthen immune-based therapies.